Neurological manifestations, laboratory and neuroimaging features in HIV-infected patients

References

1. ↵
   1. Centers for Disease Control and Prevention

   (2010) Reported CD4+T-lymphocyte and viral load results for adults and adolescents with HIV infection - 37 states 2005-2007. HIV Surveillance Supplemental Report 16, 1–10.
2. ↵
   1. Antiretroviral Therapy Cohort Collaboration

   (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372, 293–299.
3. ↵
   1. McArthur JC,
   2. Steiner J,
   3. Sacktor N,
   4. Nath A

   (2010) Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol 67, 699–714.
4. 1. Antinori A,
   2. Arendt G,
   3. Becker JT,
   4. Brew BJ,
   5. Byrd DA,
   6. Cherner M,
   7. et al.

   (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789–1799.
5. ↵
   1. Navia BA,
   2. Jordan BD,
   3. Price RW

   (1986) The AIDS dementia complex: I Clinical features. Ann Neurol 19, 517–524.
6. ↵
   1. McArthur JC,
   2. Brew BJ,
   3. Nath A

   (2005) Neurological complications of HIV infection. Lancet Neurol 4, 543–555.
7. ↵
   1. Shah R,
   2. Bag AK,
   3. Chapman PR,
   4. Cure JK

   (2010) Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65, 431–439.
8. 1. Sahraian MA,
   2. Radue EW,
   3. Eshaghi A,
   4. Besliu S,
   5. Minagar A

   (2012) Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 19, 1060–1069.
9. ↵
   1. Ortiz G,
   2. Koch S,
   3. Romano JG,
   4. Forteza AM,
   5. Rabinstein AA

   (2007) Mechanisms of ischemic stroke in HIV-infected patients. Neurology 68, 1257–1261.
10. ↵
    1. Matta F,
    2. Yaekoub AY,
    3. Stein PD

    (2008) Human immunodeficiency virus infection and risk of venous thromboembolism. Am J Med Sci 336, 402–406.
11. ↵
    1. Kure K,
    2. Llena JF,
    3. Lyman WD,
    4. Soeiro R,
    5. Weidenheim KM,
    6. Hirano A,
    7. et al.

    (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22, 700–710.
12. ↵
    1. Brew BJ,
    2. Rosenblum M,
    3. Cronin K,
    4. Price RW

    (1995) AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 38, 563–570.
13. ↵
    1. Vargas D,
    2. Nascimbene C,
    3. Lee A,
    4. Williams J,
    5. McArthur J,
    6. Pardo C

    (2005) Chemokine and cytokine profiling by protein array technology shows the basal ganglia as the most affected area in HIV dementia [abstract]. 12th Conference on Retroviruses and Opportunistic Infections (Boston (MA)).
14. ↵
    1. Tan IL,
    2. McArthur JC

    (2012) HIV-associated neurological disorders: a guide to pharmacotherapy. CNS Drugs 26, 123–134.
15. ↵
    1. Charlier C,
    2. Dromer F,
    3. Lévêque C,
    4. Chartier L,
    5. Cordoliani YS,
    6. Fontanet A,
    7. et al.

    (2008) Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One 3, e1950.
16. ↵
    1. Jehangir W,
    2. Sareen R,
    3. Sen S,
    4. Raoof N,
    5. Yousif A

    (2014) Acute Confusional State: A Manifestation of Toxoplasma and CMV Co-infection in HIV Patient. N Am J Med Sci 6, 545–548.
17. ↵
    1. Wang JY,
    2. Pan J,
    3. Luo BY,
    4. Zhang YY

    (2011) Temporal coincidence of myasthenia gravis and Guillain Barre syndrome associated with Hashimoto thyroiditis. Neurol Sci 32, 515–517.
18. ↵
    1. Kohli RS,
    2. Bleibel W,
    3. Bleibel H

    (2007) Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient with Hashimoto's thyroiditis. Am J Hematol 82, 307–308.
19. ↵
    1. Graber P,
    2. Rosenmund A,
    3. Probst A,
    4. Zimmerli W

    (2000) Multiple sclerosis-like illness in early HIV infection. AIDS 14, 2411–2413.
20. ↵
    1. Blanche P,
    2. Diaz E,
    3. Gombert B,
    4. Sicard D,
    5. Rivoal O,
    6. Brezin A

    (2000) Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 68, 795–796.
21. ↵
    1. Delgado SR,
    2. Maldonado J,
    3. Rammohan KW

    (2014) CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review. J Neurovirol 20, 531–537.
22. ↵
    1. Ndakotsu MA,
    2. Salawu L,
    3. Durosinmi MA

    (2009) Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med 18, 208–210.
23. ↵
    1. Lowe DM

    (2010) The erythrocyte sedimentation rate in HIV: a neglected parameter? AIDS 24, 2773–2775.